1. Home
  2. LEGN vs CUZ Comparison

LEGN vs CUZ Comparison

Compare LEGN & CUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • CUZ
  • Stock Information
  • Founded
  • LEGN 2014
  • CUZ 1958
  • Country
  • LEGN United States
  • CUZ United States
  • Employees
  • LEGN N/A
  • CUZ N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • CUZ Real Estate Investment Trusts
  • Sector
  • LEGN Health Care
  • CUZ Real Estate
  • Exchange
  • LEGN Nasdaq
  • CUZ Nasdaq
  • Market Cap
  • LEGN 5.4B
  • CUZ 4.7B
  • IPO Year
  • LEGN 2020
  • CUZ N/A
  • Fundamental
  • Price
  • LEGN $34.00
  • CUZ $30.49
  • Analyst Decision
  • LEGN Strong Buy
  • CUZ Buy
  • Analyst Count
  • LEGN 12
  • CUZ 9
  • Target Price
  • LEGN $77.09
  • CUZ $32.00
  • AVG Volume (30 Days)
  • LEGN 2.0M
  • CUZ 1.7M
  • Earning Date
  • LEGN 08-08-2025
  • CUZ 07-24-2025
  • Dividend Yield
  • LEGN N/A
  • CUZ 4.21%
  • EPS Growth
  • LEGN N/A
  • CUZ N/A
  • EPS
  • LEGN N/A
  • CUZ 0.34
  • Revenue
  • LEGN $728,303,000.00
  • CUZ $892,818,000.00
  • Revenue This Year
  • LEGN $65.49
  • CUZ $13.49
  • Revenue Next Year
  • LEGN $53.76
  • CUZ $4.42
  • P/E Ratio
  • LEGN N/A
  • CUZ $89.71
  • Revenue Growth
  • LEGN 112.46
  • CUZ 10.04
  • 52 Week Low
  • LEGN $27.34
  • CUZ $22.16
  • 52 Week High
  • LEGN $60.87
  • CUZ $32.55
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 53.16
  • CUZ 66.76
  • Support Level
  • LEGN $33.84
  • CUZ $30.00
  • Resistance Level
  • LEGN $35.29
  • CUZ $30.80
  • Average True Range (ATR)
  • LEGN 1.96
  • CUZ 0.62
  • MACD
  • LEGN 0.24
  • CUZ 0.13
  • Stochastic Oscillator
  • LEGN 52.16
  • CUZ 90.03

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About CUZ Cousins Properties Incorporated

Cousins Properties Inc is a real estate investment trust principally involved in the ownership, management, and development of properties in the Southern United States. Cousins Properties' real estate portfolio mainly comprises offices and mixed-use developments that encompass both apartment and retail space. Offices make up the vast majority of the portfolio in terms of total square footage. The segments operates in following geographical areas: Atlanta, Austin, Charlotte, Dallas, Phoenix, Tampa, and other markets. The company derives nearly all of its revenue in the form of rental income from its properties, the majority of which comes from its office locations. A diverse set of tenants in the cities of Houston and Atlanta represent the company's key markets.

Share on Social Networks: